Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOX in Unknown Primary Cancer
NCT00353145Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2004
- Primary completion
- Mar 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, gemcitabine in cancer of unknown primary (CUP), sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2004; status: completed.
02
Drugs
oxaliplatingemcitabine
03
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on NCT00353145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353145.